indazoles has been researched along with pargyline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bert, L; Denoroy, L; Desvignes, C; Lambás-Señas, L; Renaud, B; Vinet, L | 2 |
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kurosaki, R; Matsubara, M; Michimata, M; Mikami, T; Muramatsu, Y | 1 |
| Araki, T; Imai, Y; Kurosaki, R; Matsubara, M; Michimata, M; Muramatsu, Y; Watanabe, H | 1 |
| Fujita, K; Hosogi, J; Imamura, T; Kuwabara, T; Maeda, H; Ohashi, R; Ushiki, J; Yamamoto, Y | 1 |
5 other study(ies) available for indazoles and pargyline
| Article | Year |
|---|---|
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, Micellar Electrokinetic Capillary; Dopamine; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pargyline; Rats; Rats, Sprague-Dawley | 1999 |
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electrophysiology; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Rats; Rats, Sprague-Dawley | 1999 |
Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Arginine; Brain Chemistry; Dopamine; Dopamine Agents; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neostriatum; Neurotoxicity Syndromes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Tyrosine 3-Monooxygenase | 2002 |
Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pargyline; Parvalbumins; Protective Agents; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
An iminium ion metabolite hampers the production of the pharmacologically active metabolite of a multikinase inhibitor KW-2449 in primates: irreversible inhibition of aldehyde oxidase and covalent binding with endogenous proteins.
Topics: Aldehyde Oxidase; Animals; Carbon Isotopes; Humans; Indazoles; Macaca fascicularis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Pargyline; Piperazines; Protein Binding; Proteins; Radioligand Assay; Sodium Cyanide | 2018 |